000153221 001__ 153221
000153221 005__ 20240229133153.0
000153221 0247_ $$2doi$$a10.3390/jcm9010268
000153221 0247_ $$2pmid$$apmid:31963737
000153221 037__ $$aDKFZ-2020-00261
000153221 041__ $$aeng
000153221 082__ $$a610
000153221 1001_ $$00000-0003-0048-5047$$aRiegger, Jana$$b0
000153221 245__ $$aSerum Cartilage Oligomeric Matrix Protein in Late-Stage Osteoarthritis: Association with Clinical Features, Renal Function, and Cardiovascular Biomarkers.
000153221 260__ $$aBasel$$bMDPI$$c2020
000153221 3367_ $$2DRIVER$$aarticle
000153221 3367_ $$2DataCite$$aOutput Types/Journal article
000153221 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1636705027_5415
000153221 3367_ $$2BibTeX$$aARTICLE
000153221 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000153221 3367_ $$00$$2EndNote$$aJournal Article
000153221 520__ $$aThis study aimed to assess associations between serum cartilage oligomeric matrix protein (sCOMP) and phenotypic characteristics in late-stage hip and knee Osteoarthritis (OA) as well as its correlation with further serum markers of possible comorbidities in the Ulm Osteoarthritis Study. Moreover, the prognostic relevance of preoperative sCOMP concentrations for short-term functionality and pain outcomes after hip or knee joint replacement was explored. Preoperative serum samples and detailed information about the health status (i.e., WOMAC scores, Hannover Functionality Status (FFbH)) of 754 OA patients undergoing total joint replacement were included. Spearman rank-correlation coefficients and multiple linear regression models were used to evaluate the relationships between sCOMP, other serum markers, and health outcomes. There was a significant positive association between sCOMP and markers of renal (cystatin C, creatinine, and eGFR) and cardiac (e.g., NT-proBNP) impairment. Since renal failure might cause accumulation of sCOMP, additional adjustment with eGFR was performed. Preoperative sCOMP levels in knee OA but not hip OA patients were positively associated with FFbH, WOMAC function sub-scale and total WOMAC scale as well as the post-operative WOMAC stiffness sub-scale six months after surgery. Our data clearly demonstrate an association between sCOMP and renal function as well as other confounding factors, which should be considered in future biomarker studies.
000153221 536__ $$0G:(DE-HGF)POF3-323$$a323 - Metabolic Dysfunction as Risk Factor (POF3-323)$$cPOF3-323$$fPOF III$$x0
000153221 588__ $$aDataset connected to CrossRef, PubMed,
000153221 7001_ $$aRehm, Martin$$b1
000153221 7001_ $$aBüchele, Gisela$$b2
000153221 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b3$$udkfz
000153221 7001_ $$aGünther, Klaus-Peter$$b4
000153221 7001_ $$aRothenbacher, Dietrich$$b5
000153221 7001_ $$aBrenner, Rolf E$$b6
000153221 773__ $$0PERI:(DE-600)2662592-1$$a10.3390/jcm9010268$$gVol. 9, no. 1, p. 268 -$$n1$$p268$$tJournal of Clinical Medicine$$v9$$x2077-0383$$y2020
000153221 909CO $$ooai:inrepo02.dkfz.de:153221$$pVDB
000153221 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000153221 9131_ $$0G:(DE-HGF)POF3-323$$1G:(DE-HGF)POF3-320$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lHerz-Kreislauf-Stoffwechselerkrankungen$$vMetabolic Dysfunction as Risk Factor$$x0
000153221 9141_ $$y2020
000153221 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ CLIN MED : 2017
000153221 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000153221 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000153221 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000153221 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000153221 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000153221 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review
000153221 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000153221 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000153221 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000153221 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000153221 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000153221 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000153221 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJ CLIN MED : 2017
000153221 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000153221 980__ $$ajournal
000153221 980__ $$aVDB
000153221 980__ $$aI:(DE-He78)C070-20160331
000153221 980__ $$aUNRESTRICTED